Integrins play key roles in cell-to-cell and cell-to-extracellular matrix (ECM) adhesion. We investigated integrin expression on pleural mesothelial cells (PMCs) and the inhibitory effect of arginine-glycine-asparate (RGD)-containing peptide on the adhesion of PMCs to fibronectin and collagen.
Introduction
Pleural mesothelial cells (PMCs) in the parietal and visceral layers actively respond to extrinsic stimuli such as asbestos fibres and micro-organisms, and to intrinsic inflammatory mediators, resulting in the production of cytokines, growth factors and extracellular matrix (ECM) (1, 2) . Many studies have demonstrated that PMCs can produce a broad spectrum of matrix components, including at least three collagen types (I, III, IV), elastin, fibronectin and laminin (3, 4) .
Cell-to-cell and cell-to-ECM adhesion has roles in embryonic development, maintenance of tissue architecture, inflammatory response, tumour metastasis and wound healing (5) (6) (7) . Integrins, a family of cell adhesion molecules, are heterodimers (a and b) that mediate cell-to-cell and extracellular connections (8, 9) . Ligands of integrins include collagen, laminin, fibronectin, fibrinogen and thrombospondin (10, 11) . After interaction with ligands, the intracellular domains of integrins form connections with cytoskeleton that effect cell morphological change and may be related to cellular attachment and detachment. In response to asbestos, integrins on rabbit pleural mesothelial cells can interact with ECM, causing the measothelial cells to change shape (12) .
The role of integrins in the adhesion of mesothelial cells to pleural ECM in response to pleural injury has not been widely reported previously. The purpose of this study was to investigate the expression of integrins on human PMCs, including primary human cell culture and immortalized mesothelial cells (Met-5A). Mesothelial cells freshly isolated from pleural effusions and Met-5A cells were screened for different integrins using flow cytometry and immunostaining, and the immunohistochemistry of intact pleural tissue was evaluated. Disruption of cell-matrix interaction by arginine-glycine-aspartate (RGD)-containing peptide has been shown to cause a number of diseases and pathogenic processes (13, 14) . We therefore tested the inhibitory effect of RGD-containing peptide on the adhesion of mesothelial cells to fibronectin and collagen.
Materials and methods

REAGENTS
The screening antibodies conjugated to fluorescein isothiocyanate (FITC) were purchased from Becton Dickinson Immunocytometry System (San Jose, CA, U.S.A.). Mouse monoclonal antibody to cytokeratin (types I and II), vimentin, CEA and desmin, and rabbit immunoglobulins to von Willebrand factor antigen, were obtained from Dakopatts (Denmark). Anti-integrin monoclonal antibodies (mAbs) a1 (TS2/7), a2(JBS2), a3(11G5), a4(44H6), a5(JB55), a6(4F10), avb3(23C6), b1(3S3) and b3(PM6/13) were purchased from Serotec (Kidlington, Oxford, U.K.). Extracellular matrix (ECM), including fibronectin (from bovine plasma), collagen type III (acid-soluble from human placenta) and collagen type IV (acid-soluble from human placenta), was purchased from Sigma Chemical (St. Louis, MO, U.S.A.) as was glycine-arginine -glycine aspartateserine (GRGDS) peptide. Collagen type I (from bovine skin, vitrogen) was purchased from Celtrix Laboratories (Palo Alto, CA, U.S.A.).
ISOLATION AND CULTURE OF HUMAN PLEURAL MESOTHELIAL CELLS
Patients with moderate to massive pleural effusions underwent thoracentesis for relieving respiratory distress. The effusions were collected before chest tube insertion or other interventions. Cytology for malignancy, biochemistry (total protein, lactic dehydrogenase and sugar), cell counts and cultures for micro-organisms were all checked on the pleural effusion specimens.
Mesothelial cells were obtained from patients with pleural effusion as described in previous reports (15, 16) . Red blood cells in the effusions were removed by gradient centrifugation. Then the pellet was washed once in RPMI 1640, resuspended in the same medium to a volume of 8-10 ml and seeded in 75-cm 2 vitrogen-coated tissue culture flasks in RPMI 1640 with 10% fetal calf serum. The mesothelial cell cultures were maintained for two or three passages at 378C in a humidified environment containing 5% CO 2 . Mesothelial cells were identified by their morphological and immunohistochemical features: positive staining for human cytokeratin (types I and II) and vimentin and negative staining for CEA, desmin and von Willebrand factor (17) . The Met-5A mesothelial cell line, produced from non-cancerous pleural effusion, was purchased from American Type Culture Collection (Manassas, VA, U.S.A.). The cells were transfected with pRSV-T plasmid (containing the SV40 early region and the Rous sarcoma virus long terminal repeat) and cloned. Medium 199 was used with 5% fetal bovine serum.
FLOW CYTOMETRY ANALYSIS
After trypsinizing and washing, 0?571610 6 cells were incubated with anti-integrin monoclonal antibodies (30 mg ml 71 ) for 30 min at 48C and washed with PBS. In negative controls, the primary antibody was omitted. Subsequently, cells were incubated with FITC-conjugated goat anti-mouse IgG or anti-rat IgG 30 min at 48C and again washed with PBS. Finally, fluorescence intensity was analysed using the FACScan (Becton Dickinson, Mountain View, CA, U.S.A.).
IMMUNOSTAINING OF PMCs AND PLEURAL TISSUE
PMCs grown on cover slips were fixed with 0?1% paraformaldehyde in PBS for 10 min. After washing, the cells were incubated with 20% normal goat whole serum in PBS at 378C for 30 min to block non-specific binding. After extensive rinsing, the cells were incubated with monoclonal anti-integrin subunit antibodies at 378C for 60 min. After washing, cells were incubated with FITC-conjugated goat anti-mouse or anti-rat antibody at 378C for 60 min. In negative controls, the primary antibody was omitted.
Sections from eight pleural tissues, obtained from patients who underwent lobectomy for bronchial tumour, were cut at 10 mm in a cryostatic state. The immunohistochemistry was evaluated using the standard ABC (avidin-biotin peroxidase complex) detecting system (18).
MET-5A MESOTHELIAL CELL ADHESION ASSAY
Met-5A cells were suspended in M199 medium at a concentration of 2610 5 cells ml 71 . Ninety-six-well tissue culture plates had been separately coated with 50 ml of fibronectin (30 mg ml 71 ), collagen type I (80 mg ml 71 ), collagen type III (80 mg ml
71
) and collagen type IV (80 mg ml 71 ) in PBS. After coating overnight at 48C, the culture plates were washed with medium 199. Non-specific binding was blocked with 50 ml of 1% BSA in medium 199 for 60 min at 378C. A 200-ml aliquot of cells was pretreated with various concentrations of GRGDS peptide (1?5, 15, 150 mg ml 71 ) dissolved in M199 culture medium and incubated for 30 min in 5% CO 2 at 378C. Cells were then placed into each well and incubated for 90 min at 378C. Instead of GRGDS, we used M199 culture medium as controls in each group. Non-adherent cells were removed by aspiration and the attached cells were washed gently with PBS. Adherent cells were fixed with 0?1% paraformaldehyde for 10 min and stained with crystal violet for 1 min. Adhesion was assessed by counting adherent cells using a 1-mm 2 reticle in an eyepiece at 6100 magnification in an inverted phase-contrast microscope. All experiments were repeated in quadruplicate.
STATISTICAL ANALYSIS
Statistical analysis was calculated by the Mann-Whitney Utest or repeated measures ANOVA. A P-value less than 0?05 was considered statistically significant.
Results
PATIENTS
During a 1-year study period, pleural effusions were collected from 26 patients for isolation of mesothelial cells. There were 13 women and 13 men whose ages ranged from 15 to 78 years. Their underlying diseases included six cases of liver cirrhosis, one liver abscess, two congestive heart failures, one systemic lupus erythematosus, one Waldenstrom macroglobulinemia, nine primary lung cancers (eight were non-small cell lung cancers) and six metastatic lung cancers. The characteristics of pleural effusion included eight transudates and 18 exudates. Eighteen were negative and eight positive for malignancy.
INTEGRIN EXPRESSION ON PLEURAL MESOTHELIAL CELLS AND MET-5A CELLS
Using flow cytometry, the expression of integrins on primary PMCs can be arbitrarily classified into three categories: high (470%), intermediate (30-70%) and low (530%). a2, a3, a5, b1, b3 and avb3 were highly expressed on the primary PMCs. The expression of a1 was intermediate, and expressions of a4 and a6 were low (Table 1) . Immunostaining results were consistent with the flow cytometry. Monoclonal antibodies specific to a2, a3, a5, b1, b3 and avb3 were present in the PMCs grown on cover slips [ Fig. 1(a) ] and there were fluorescence clusters on the cellular surface. Fluorescence density was greater on the cytoplasm membrane borders. The expression of integrins on Met-5A cells showed that a3, a5, a6 and b1 were high on the surface, a1 was intermediate and a2, a4, b3 and avb3 were low (Table 1 ). The expressions of a2, a6, b3 and avb3 were different on primary PMCs and the Met-5A cell line.
The patterns of immunostaining on pleural tissues were consistently similar to the results of flow cytometry for the primary cultured PMCs. Integrins a2, a3, a5, b1 and avb3 were expressed on the cytoplasmic membrane of the flat PMCs in the uppermost layer of the pleura [ Fig. 1(b) ]. Staining for a1, a4, a6 and b3 was negative.
There was no significantly different expression between transudative and exudative effusions [ Fig. 2(a) ]. There also was no difference between benign and malignant effusions [ Fig. 2(b) ]. 
ADHESION ASSAY
To avoid subjective selection, counting was analysed by two persons who did not know the experimental conditions. Since cells frequently adhere at the sharp edge on the border of each well, adherent cells were counted exclusively in these areas, as in a previous study (19) . In each control well (n ¼ 4), adherent cells from six randomized sampling 1-mm 2 areas were 1481+209 (mean+SD) for collagen I, 1190+154 for collagen III, 1378+133 for collagen IV and 1627+144 for fibronectin. Figure 3 , presenting inhibition percentage, showed that GRGDS inhibited Met-5A cell adhesion to all four matrix proteins in a dose-dependent manner. With 1?5 mg ml 71 GRGDS pretreatment, the inhibition effect on collagen I and collagen III was significantly higher than that on collagen IV and fibronectin (P50?05 by ANOVA analysis). With 15 mg ml 71 GRGDS pretreatment, the inhibition effect on collagen I and fibronectin was significantly higher than that on collagen III and collagen IV (P50?05). With 150 mg ml71 GRGDS pretreatment, the inhibition effect on fibronectin was the most potent more than that on collagen I, III and IV (P50?05).
Discussion
The subunits of integrins are expressed differently on different cell types. Cultured mammalian cell lines possess two to 10 integrins (7). In our study, flow cytometry showed that more than 70% of the primary PMCs were positive for a2, a3, a5, b1, b3 and avb3. Immunostaining showed the same findings. However, on the Met-5A cell line the expression of a2, b3 and avb3 decreased and a6 increased. Immortalized transformation may cause the integrin changes on cell surfaces. This result is compatible with the study of integrin expression on pleural mesothelioma and mesothelioma cell line (20, 21) . The expression of a6 is intimately associated with neoplastic phenotype. The different histotypes can affect in-vitro integrin expression and may indicate a potential involvement of some subunits in vivo during malignant mesothelioma tumour progression (22) .
To determine the possibility of integrin change on PMCs in culture, we examined the immunostaining of intact pleural tissue. The patterns of immunostaining on the pleura were similar to the flow cytometry except for b3. The mesothelial cells on intact pleural tissue showed almost the same integrin distribution as cultured cells. Integrin did not change markedly in culture from the in-situ state. However, the number of samples in this study was limited and further investigation of the pleural tissues of various diseases in needed.
The molecular mechanisms of desquamation of PMCs in pleural injuries remain unknown. Disruption of cell-matrix interaction, mediating integrin-dependent events, may lead to cellular detachment and aggregation of desquamated cells (21, 23) . The counts of PMCs in pleural effusions are significantly different in a variety of diseases. These cells are uncommon in tuberculosis effusions but more common in transudative effusions. We tested whether or not the desquamation of PMCs occurs through changes of integrins (24) . However, our study failed to find significant changes in the expression of integrins on PMCs in various disease states (transudate vs. exudate; benign vs. malignant). Desquamation may be caused by direct injury to submesothelial ECM without integrin changes on PMCs. Werb reported that proteolytic enzymes, produced by both inflammatory cells and malignant cells, lead to change in pleural permeability and pleural effusion formation (25) . Those enzymes could degrade the components of subpleural ECM, resulting in a loss of both structural integrity and cellular relationships. It is known that both fibronectin and laminin are subject to proteolytic attack by neutral protease and can be degraded in an inflammatory milieu (26) . Proteolytic degradation of ECM may account for the detachment of mesothelial cells in vivo, but this theory must remain a speculation with these data derived only from invitro culture.
Integrins have three binding models: RGD for cellmatrix, ICAM for cell-to-cell and fibrinogen (aIIbb3) for platelets. The RGD binding site is found in a number of ligands that interact with integrins including fibronectin, vitronectin, collagen and a variety of other adhesive proteins (27) . The pairing of a and b exhibits high fidelity in certain tissues and cell types. Approximately half the known integrins, including a3b1, a5b1, avb1, avb3 and avb5, express an RGD recognition specificity. In this study, a synthetic RGD-containing peptide (GRGDS) inhibited Met-5A cell adhesion to collagen types I, III and IV, and fibronectin in a dose-dependent manner. Study of cell adhesion inhibition by RGD peptides through integrinmediated processes should exclude the non-specific toxicity of GRGDS. Previous studies showed incubation of peritoneal mesothelial cells with GRGDS did not affect cell viability (28) . We also found the viability of PMCs was not affected by GRGDS after 90 min of incubation. At 150 mg ml 71 , GRGDS was more potent in inhibiting fibronectin-and collagen type I-than III-an IV-mediated adhesion of Met-5A cells. This finding indicates that, as do other types of cells [e.g. peritoneal mesothelial cells (28) ], PMCs possess RGD-dependent receptors.
A number of diseases and pathogenic processess are candidates for intervention with RGD mimics. The arginine-glycine-asparate (RGD) sequence of filamentous haemagglutinin of Bordetella pertussis inhibited adherence and transendothelial migration of neutrophils in an experimental model of meningitis in rabbits (13) . In the study by Curtis et al., RGD-containing peptides altered the endothelial permeability of bovine lung endothelial monolayers (14) , suggesting that disruption of cell-matrix interaction by RGD-containing peptides may be the mechanism for change in cellular permeability. However, the effect of RGD-containing peptides in permeability of PMCs needs further investigation.
In conclusion, this study has established the characteristic profiles for integrin expression on the surface of human pleural mesothelial cells. a2, a3, a5, b1, b3 and avb3 are highly expressed on primary cultured human PMCs and a3, a5, a6 and b1 are highly expressed on the Met-5A cell line. RGD-containing peptide can inhibit the adhesion of mesothelial cells to ECM, including collagen I, III, IV and fibronectin.
